Home Clinical Topics FDA approves new drug for eczema

FDA approves new drug for eczema

On March 28, the U.S. Food and Drug Administration (FDA) approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here